<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="1740">
  <stage>Registered</stage>
  <submitdate>8/11/2007</submitdate>
  <approvaldate>8/11/2007</approvaldate>
  <nctid>NCT00555958</nctid>
  <trial_identification>
    <studytitle>Vagal Blocking for Obesity Control</studytitle>
    <scientifictitle>VBLOC Clinical Trial: Vagal Block for Obesity Control</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>D00292-000</secondaryid>
    <secondaryid>VBLOC</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Obesity</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and Nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Other metabolic disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - Active, implantable, intra-abdominal vagal blocking medical device

Experimental: A - All study subjects will be implanted with the Maestro System, and all will receive VBLOC therapy.


Treatment: devices: Active, implantable, intra-abdominal vagal blocking medical device
Intermittent, programmable, intra-abdominal vagal blocking

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Excess weight loss (EWL)</outcome>
      <timepoint>4 and 12 weeks, and 6, 12, 24, 36, 48 and 60 months</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Serious Adverse Events (SAE) and Unanticipated Adverse Device Effects (UADE)</outcome>
      <timepoint>4 and 12 weeks, and 6, 12, 24, 36, 48 and 60 months</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Body mass index (BMI) 35-50 +/- 10% inclusive

          -  Failure to respond to diet/exercise program</inclusivecriteria>
    <inclusiveminage>25</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>60</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  History of gastric resection or major upper-abdominal surgery (e.g. cholycystectomy,
             hysterectomy acceptable)

          -  Current type 1 diabetes mellitus (DM) or poorly controlled type 2 DM

          -  Reductions of more than 10% of body weight in the previous 12 months

          -  Current medical condition that would make subject unfit for surgery under general
             anesthesia or that would be exacerbated by intentional weight loss</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/11/2005</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>120</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Unknown status</recruitmentstatus>
    <anticipatedlastvisitdate>1/09/2014</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>SA</recruitmentstate>
    <hospital>Flinders Medical Centre - Bedford Park</hospital>
    <hospital>Institute of Weight Control - Sydney</hospital>
    <postcode>5042 - Bedford Park</postcode>
    <postcode>2153 - Sydney</postcode>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Mexico City</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Norway</country>
      <state>Trondheim</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Switzerland</country>
      <state>Basel</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>EnteroMedics</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>To determine the safety, efficacy and treatment algorithm(s) of the Maestro System in causing
      weight loss in obese subjects - This study will provide feasibility data regarding the
      potential of intra-abdominal vagus nerve down-regulation/block in the treatment of obesity.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00555958</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>